Impact of Donor-imposed Requirements and Restrictions on Standards of Prevention and Access to Care and Treatment in HIV Prevention Trials
Impact of Donor-imposed Requirements and Restrictions on Standards of Prevention and Access to Care and Treatment in HIV Prevention Trials
复制标题
DOI:
10.1093/phe/phq027
复制
发表时间:
2010-11-01
影响因子:
2.1
通讯作者:
Heise, Lori
中科院分区:
文献类型:
--
作者:
Philpott, Sean;Slevin, Katherine West;Heise, Lori
The number of women living with HIV/AIDS is increasing worldwide, and there is an urgent public health need to develop new user-initiated HIV prevention methods, including microbicides. Although funding for microbicide development has increased since 2000, financial support is provided predominantly by governmental agencies and private foundations. Many donors, including the US Agency for International Development (USAID) and the US National Institutes of Health (NIH), have policies that restrict how research funds may be used. Among these are the now-rescinded Mexico City Policy, elements of the US Foreign Assistance Act, and restrictions on non-study-related care. The effect of these restrictions on the design and conduct of clinical research is poorly understood. As part of a recent mapping exercise conducted by the Global Campaign for Microbicides, we reviewed the impact of donor restrictions on seven HIV prevention trials. We found considerable confusion within the HIV prevention field as to whether and how Mexico City and other policies affect the use of research funds. We also found that these donor-imposed policies limited the level of care provided to trial participants and the types of capacity building projects undertaken.